104 related articles for article (PubMed ID: 15207680)
1. Hormone replacement therapy and mammographic density.
Kilicdag EB; Bagis T; Pourbagher A; Tarim E
Int J Gynaecol Obstet; 2004 Jul; 86(1):56-8. PubMed ID: 15207680
[No Abstract] [Full Text] [Related]
2. Estrogen-plus-progestin use and mammographic density in postmenopausal women: Women's Health Initiative randomized trial.
McTiernan A; Martin CF; Peck JD; Aragaki AK; Chlebowski RT; Pisano ED; Wang CY; Brunner RL; Johnson KC; Manson JE; Lewis CE; Kotchen JM; Hulka BS;
J Natl Cancer Inst; 2005 Sep; 97(18):1366-76. PubMed ID: 16174858
[TBL] [Abstract][Full Text] [Related]
3. Menopausal hormone therapies: their effect on mammographic density and breast cancer risk.
Santen R
Gynecol Endocrinol; 2005 Jul; 21 Suppl 1():12-6. PubMed ID: 16112950
[TBL] [Abstract][Full Text] [Related]
4. Histologic changes in the breast with menopausal hormone therapy use: correlation with breast density, estrogen receptor, progesterone receptor, and proliferation indices.
Harvey JA; Santen RJ; Petroni GR; Bovbjerg VE; Smolkin ME; Sheriff FS; Russo J
Menopause; 2008; 15(1):67-73. PubMed ID: 17558338
[TBL] [Abstract][Full Text] [Related]
5. Pain and increased mammographic density in women receiving hormone replacement therapy: a prospective study.
McNicholas MM; Heneghan JP; Milner MH; Tunney T; Hourihane JB; MacErlaine DP
AJR Am J Roentgenol; 1994 Aug; 163(2):311-5. PubMed ID: 8037021
[TBL] [Abstract][Full Text] [Related]
6. Is mammographic density, as currently measured, a robust surrogate marker for breast cancer?
Yaffe M; Hendrix S; Pike M; Santen R; Eden J; Genazzani A
Gynecol Endocrinol; 2005 Jul; 21 Suppl 1():17-21. PubMed ID: 16112951
[TBL] [Abstract][Full Text] [Related]
7. Hormone replacement therapy, percent mammographic density, and sensitivity of mammography.
Kavanagh AM; Cawson J; Byrnes GB; Giles GG; Marr G; Tong B; Gertig DM; Hopper JL
Cancer Epidemiol Biomarkers Prev; 2005 May; 14(5):1060-4. PubMed ID: 15894653
[TBL] [Abstract][Full Text] [Related]
8. [A mammographic evaluation of the morphostructural variations of the breast during hormone-replacement therapy in the postmenopause].
Porfiri LM; Costanza L; De Felice C; Perrone G; David V; Zichella L
Radiol Med; 1998 Jun; 95(6):573-6. PubMed ID: 9717537
[TBL] [Abstract][Full Text] [Related]
9. Effect of estrogen-progestin and estrogen on mammographic density.
Kaewrudee S; Anuwutnavin S; Kanpittaya J; Soontrapa S; Sakondhavat C
J Reprod Med; 2007 Jun; 52(6):513-20. PubMed ID: 17694969
[TBL] [Abstract][Full Text] [Related]
10. [Breast density: a major parameter to follow during hormone replacement therapy].
Gairard B; Guldenfels C; Haehnel P; Mathelin C
Gynecol Obstet Fertil; 2009; 37(7-8):657-60. PubMed ID: 19577502
[TBL] [Abstract][Full Text] [Related]
11. Unilateral increase in mammographic density with hormone replacement therapy.
Doyle GJ; McLean L
Clin Radiol; 1994 Jan; 49(1):50-1. PubMed ID: 8299332
[TBL] [Abstract][Full Text] [Related]
12. Short-term cessation of hormone replacement therapy and improvement of mammographic specificity.
Harvey JA; Pinkerton JV; Herman CR
J Natl Cancer Inst; 1997 Nov; 89(21):1623-5. PubMed ID: 9362162
[No Abstract] [Full Text] [Related]
13. Mammographic density changes in women on hormone replacement therapy.
Dalessandri KM
Climacteric; 2002 Mar; 5(1):92-3. PubMed ID: 11974566
[No Abstract] [Full Text] [Related]
14. Effects of hormone replacement therapy on mammographic findings.
Bülbül NH; Ozden S; Dayicioglu V
Arch Gynecol Obstet; 2003 Apr; 268(1):5-8. PubMed ID: 12673467
[TBL] [Abstract][Full Text] [Related]
15. The need for tissue selective menopausal agents.
Eden J
Gynecol Endocrinol; 2005 Jul; 21 Suppl 1():22-7. PubMed ID: 16112952
[TBL] [Abstract][Full Text] [Related]
16. Mammographic density, response to hormones, and breast cancer risk.
Boyd NF; Melnichouk O; Martin LJ; Hislop G; Chiarelli AM; Yaffe MJ; Minkin S
J Clin Oncol; 2011 Aug; 29(22):2985-92. PubMed ID: 21709206
[TBL] [Abstract][Full Text] [Related]
17. [Changes in mammography and breast ultrasonography in women undergoing hormonal replacement therapy].
Rzymski P; Szpakowska-Rzymska I; Wilczak M; Warenik-Szymankiewicz A; Sajdak S
Ginekol Pol; 2001 Oct; 72(10):809-15. PubMed ID: 11848018
[TBL] [Abstract][Full Text] [Related]
18. The meaning of mammographic breast density in users of postmenopausal hormone therapy.
Speroff L
Maturitas; 2002 Mar; 41(3):171-5. PubMed ID: 11886762
[No Abstract] [Full Text] [Related]
19. Does a short cessation of HRT decrease mammographic density?
Weaver K; Kataoka M; Murray J; Muir B; Anderson E; Warren R; Warsi I; Highnam R; Glasier A
Maturitas; 2008 Apr; 59(4):315-22. PubMed ID: 18448281
[TBL] [Abstract][Full Text] [Related]
20. Re: Breast cancer incidence, 1980-2006: combined roles of menopausal hormone therapy, screening mammography, and estrogen receptor status.
Chu DZ
J Natl Cancer Inst; 2008 Apr; 100(8):596-7. PubMed ID: 18398103
[No Abstract] [Full Text] [Related]
[Next] [New Search]
